A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.
The resistance of Candida albicans biofilms to a broad spectrum of antimicrobial agents has been well documented. Biofilms are known to be heterogeneous, consisting of microenvironments that may induce formation of resistant subpopulations. In this study we characterized one such subpopulation. C. albicans biofilms were cultured in a tubular flow cell (TF) for 36 h. The relatively large shear forces imposed by draining the TF removed most of the biofilm, which consisted of a tangled mass of filamentous forms with associated clusters of yeast forms. This portion of the biofilm exhibited the classic architecture and morphological heterogeneity of a C. albicans biofilm and was only slightly more resistant than either exponential- or stationary-phase planktonic cells. A submonolayer fraction of blastospores that remained on the substratum was resistant to 10 times the amphotericin B dose that eliminated the activity of the planktonic populations. A comparison between planktonic and biofilm populations of transcript abundance for genes coding for enzymes in the ergosterol (ERG1, -3, -5, -6, -9, -11, and -25) and beta-1,6-glucan (SKN and KRE1, -5, -6, and -9) pathways was performed by quantitative RT-PCR. The results indicate a possible association between the high level of resistance exhibited by the blastospore subpopulation and differential regulation of ERG1, ERG25, SKN1, and KRE1. We hypothesize that the resistance originates from a synergistic effect involving changes in both the cell membrane and the cell wall.
Khot
Prasanna D
PD
Department of Microbiology and Center for Biofilm Engineering, 366 EPS, Montana State University, Bozeman, MT 59717-3980, USA.
Suci
Peter A
PA
Miller
R Lance
RL
Nelson
Raoul D
RD
Tyler
Bonnie J
BJ
D000666:Amphotericin B / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects*; D002176:Candida albicans / Q000187:drug effects* / Q000235:genetics / Q000648:ultrastructure; D017931:DNA Primers; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004271:DNA, Fungal / Q000096:biosynthesis / Q000235:genetics; D025141:Drug Resistance, Fungal / Q000502:physiology; D004875:Ergosterol / Q000235:genetics* / Q000378:metabolism*; D005800:Genes, Fungal / Q000235:genetics; D008826:Microbial Sensitivity Tests; D008855:Microscopy, Electron, Scanning; D012331:RNA, Fungal / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013172:Spores, Fungal / Q000187:drug effects* / Q000235:genetics / Q000648:ultrastructure; D014158:Transcription, Genetic; D047071:beta-Glucans / Q000378:metabolism*
D000935:Antifungal Agents; D017931:DNA Primers; D018076:DNA, Complementary; D004271:DNA, Fungal; D012331:RNA, Fungal; D047071:beta-Glucans; C064197:beta-1,6-glucan; D000666:Amphotericin B; D004875:Ergosterol